M&A Deal Summary

Ascendis Health Acquires Remedica

On May 24, 2016, Ascendis Health acquired life science company Remedica for 260M EUR

Acquisition Highlights
  • This is Ascendis Health’s 1st transaction in the Life Science sector.
  • This is Ascendis Health’s largest (disclosed) transaction.
  • This is Ascendis Health’s 1st transaction in Cyprus.

M&A Deal Summary

Date 2016-05-24
Target Remedica
Sector Life Science
Buyer(s) Ascendis Health
Deal Type Add-on Acquisition
Deal Value 260M EUR

Target

Remedica

Limassol, Cyprus
Remedica Ltd. is a pharmaceutical company, dedicated to the development, production and sale of quality generic pharmaceutical products.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ascendis Health

Cape Town, South Africa

Category Company
Sector Healthcare Services
Employees30
DESCRIPTION

Ascendis Health is a health and care brands company operating in plant & animal and human health. Ascendis’ strategy is to create a synergistic group of health product brands that cover the value chain from imports of raw materials, manufacturing, brands and through to distribution to consumers via retail and direct selling channels. As one part of its growth strategy Ascendis also has a strong focus on acquisitive growth utilizing the private equity deal team of its controlling shareholder Coast2Coast.


DEAL STATS #
Overall 5 of 5
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 4 of 4
Country (Cyprus) 1 of 1
Year (2016) 2 of 2
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-05-24 Scitec Holding BV

Orlando, Florida, United States

Scitec Nutrition is a producer and sells a wide variety of sports nutrition products.

Buy €170M